See All Slides - tctmd.com

Slides

Presentation TCT 2014

Organic Innovation: Corporate Perspective

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan, Jim Barry

September 13, 2014

Presentation TCT 2014

How to Be a Key Enroller in Clinical Trials: Building the Team!

Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, James C. Blankenship

September 13, 2014

Presentation TCT 2014

You Should Always Start Antegrade!

Presenter: Gerald S. Werner

September 13, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Presentation TCT 2014

Prognosis of Secondary MR in Heart Failure: New Insights from the Italian Registry

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Francesco Maisano

September 13, 2014

Presentation TCT 2014

Reflections on Transcatheter Aortic Valve Therapies from BAV to TAVR: Greatest Disappointments, Surprises, and Achievements

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Alain G. Cribier

September 13, 2014

Presentation TCT 2014

NIRS Utility in the Unstable Patient With ACS/NSTEMI

Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, David Erlinge

September 13, 2014

Presentation TCT 2014

The DCB-Only Approach Is Feasible: The Real Promise to Leave Nothing Behind!

Presenter: Franz X. Kleber

September 13, 2014

Presentation TCT 2014

Incubators and Accelerators

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan, Hanson S. Gifford

September 13, 2014

Presentation TCT 2014

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Presenter: Robert S. Schwartz

September 13, 2014

Advertisement

Slides

Organic Innovation: Corporate Perspective

How to Be a Key Enroller in Clinical Trials: Building the Team!

You Should Always Start Antegrade!

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Prognosis of Secondary MR in Heart Failure: New Insights from the Italian Registry

Reflections on Transcatheter Aortic Valve Therapies from BAV to TAVR: Greatest Disappointments, Surprises, and Achievements

NIRS Utility in the Unstable Patient With ACS/NSTEMI

The DCB-Only Approach Is Feasible: The Real Promise to Leave Nothing Behind!

Incubators and Accelerators

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content